APA (7th ed.) Citation

Zhang, H., Wang, P., Li, Z., He, Y., Gan, W., & Jiang, H. (2021). Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia. Clinical cancer research, 27(13), 3549-3555. https://doi.org/10.1158/1078-0432.CCR-20-4543

Chicago Style (17th ed.) Citation

Zhang, Hui, Pengfei Wang, Zhuoyan Li, Yingyi He, Wenting Gan, and Hua Jiang. "Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia." Clinical Cancer Research 27, no. 13 (2021): 3549-3555. https://doi.org/10.1158/1078-0432.CCR-20-4543.

MLA (9th ed.) Citation

Zhang, Hui, et al. "Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia." Clinical Cancer Research, vol. 27, no. 13, 2021, pp. 3549-3555, https://doi.org/10.1158/1078-0432.CCR-20-4543.